×
Efficacy and Safety of Pregabalin in the Treatment of Generalized Anxiety Disorder: A 6-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Comparison of Pregabalin and Venlafaxine PDF
$ 40.00
Efficacy and Safety of Pregabalin in the Treatment of Generalized Anxiety Disorder: A 6-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Comparison of Pregabalin and Venlafaxine PDF quantity
$ 40.00
×
Correlates and Variation in Early Maladaptive Schema Domains Between Day 1 and Day 15 of Menses Among Lebanese Female University Students PDF
$ 40.00
Correlates and Variation in Early Maladaptive Schema Domains Between Day 1 and Day 15 of Menses Among Lebanese Female University Students PDF quantity
$ 40.00
×
Differential Prescription of Maintenance Antipsychotics to African American and White Patients With New-Onset Bipolar Disorder PDF
$ 40.00
Differential Prescription of Maintenance Antipsychotics to African American and White Patients With New-Onset Bipolar Disorder PDF quantity
$ 40.00
×
Cytochrome P450 2D6 Phenotype Predicts Antidepressant Efficacy of Venlafaxine: A Secondary Analysis of 4 Studies in Major Depressive Disorder PDF
$ 40.00
Cytochrome P450 2D6 Phenotype Predicts Antidepressant Efficacy of Venlafaxine: A Secondary Analysis of 4 Studies in Major Depressive Disorder PDF quantity
$ 40.00
×
Treatment of Electroconvulsive Therapy–Emergent Hypomania and Mania: A Systematic Review of the Literature PDF
$ 40.00
Treatment of Electroconvulsive Therapy–Emergent Hypomania and Mania: A Systematic Review of the Literature PDF quantity
$ 40.00
×
Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder: Clinical Response in an Open-Label Extension Trial PDF
$ 40.00
Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder: Clinical Response in an Open-Label Extension Trial PDF quantity
$ 40.00
×
A Randomized Pilot Study of the Efficacy and Safety of ABT-089, a Novel α4β2 Neuronal Nicotinic Receptor Agonist, in Adults With Attention-Deficit/Hyperactivity Disorder PDF
$ 40.00
A Randomized Pilot Study of the Efficacy and Safety of ABT-089, a Novel α4β2 Neuronal Nicotinic Receptor Agonist, in Adults With Attention-Deficit/Hyperactivity Disorder PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
